Lanfranco P.
- Country
- Denmark
- Department
- Clinical Pharmacology, Pharmacy and Environmental Medicine
Research Overview
- Evaluation of the Migraine-Inducing Effects of Pitolisant in Women with Migraine Without Aura
- Single-Dose Oral Apremilast 30 mg Induction of Headache and Migraine in Women with Migraine Without Aura: A Randomized, Placebo-Controlled Study
- Investigation of Sildenafil-Induced Headache in Male and Female Patients with Episodic Migraine Without Aura: A Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 1 of 1 partner site.
Specializations
Migraine Research
This investigator specializes in studying migraine without aura, with particular emphasis on understanding headache mechanisms and therapeutic interventions.
- Episodic Migraine Management
- Gender-Specific Headache Patterns
- Migraine Attack Triggers
The research focus includes examination of pharmacological effects on headache patterns in both male and female patients experiencing episodic migraines.
Neurological Disorders
The investigator conducts research in headache disorders and their various manifestations, exploring the relationship between medications and headache occurrence.
- Medication-Induced Headaches
- Neurological Response Patterns
- Clinical Headache Assessment
Their work encompasses the study of pharmacological interventions and their effects on neurological responses in migraine patients.
Gender-Based Studies
The investigator explores gender-specific responses to therapeutic interventions in migraine treatment, comparing outcomes between male and female patients.
- Gender-Differentiated Responses
- Sex-Specific Treatment Effects
- Comparative Clinical Outcomes
Their research examines how gender influences headache manifestation and treatment response in migraine patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.